Exogenous Ketone Supplementation and Exercise Performance
The Effect of Exogenous Ketone Supplementation on 20 km Time Trial and Wingate Performance in Recreationally Active Individuals
1 other identifier
interventional
20
1 country
1
Brief Summary
20 healthy recreationally active men and woman aged 18-35 will participate in the study. There will be three treatments involved: Caffeinated ketone supplements, non-caffeinated ketone supplement and water-placebo. Participants will complete the protocol three times and the treatment order will be systematically rotated to avoid any order effect. The three main trials will be separated by at least 1 week. After providing the corresponding treatment, participants will be given 30 minutes and after, they will perform a standardized 10-minute warm-up, followed by the 20 km time trial and a 30-second all-out Wingate test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 13, 2019
CompletedFirst Posted
Study publicly available on registry
March 29, 2019
CompletedStudy Start
First participant enrolled
May 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedOctober 2, 2019
September 1, 2019
7 months
February 13, 2019
September 30, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
20 km time trial
participants will ride for 20 km on a stationary bike and time to complete distance will be measured.
40 minutes
Wingate test
participants will perform a ver short all-out effort on a stationary bike. peak power output and fatigue index will be measured.
30 seconds
Secondary Outcomes (3)
Blood Ketone
1 hour
Blood Lactate
1 hour
Rates of perceived exertion (RPE)
1 hour
Study Arms (3)
Water Placebo
PLACEBO COMPARATORPlacebo flavored drink similar to treatments but with no energy will be ingested before completing a 20km Time trial and a 30 second all-out Wingate test
Experimental 1
EXPERIMENTALKetone salts supplement mixed in water will be ingested before completing a 20km Time trial and a 30 second all-out Wingate test
Experimental 2
EXPERIMENTALKetone salts/caffeine supplement mixed in water will be ingested before completing a 20km Time trial and a 30 second all-out Wingate test
Interventions
20 km time trial cycling test will be conducted to measure the effect of different drinks on time
30 second all-out effort on a bike will be conducted to measure the effect of different drinks on peak power output
Dietary supplement containing ketone salts and caffeine
Eligibility Criteria
You may qualify if:
- Healthy male and female recreationally active individuals
- aged 15-35 years
- non regular caffeine users.
You may not qualify if:
- Smoker
- Taking part in other research
- Sedentary
- For women, if they are pregnant or become pregnant during the study
- Injury limiting exercise ability.
- Have symptoms or take medication for respiratory disease
- Have symptoms or take medication for cardiovascular disease
- Have symptoms or take mediation for neuromuscular disease
- Use heart rate or blood pressure medications
- Use any medications with side effects of dizziness, lack of motor control, or slowed reaction time
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Exercise Nutrition Laboratory (Western University)
London, Ontario, N6A 3K7, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Lemon, PhD
Western University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Participants and investigators will be blinded as an individual not involved in the project will assemble and distribute the treatment (drinks) according to a coding system that is kept confidential until the study is completed. Participants will complete the protocol three times and the treatment order will be systematically rotated to avoid any order effect. taste and texture of treatments will be matched and will be distribute in opaque bottles to keep participant blinded
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 13, 2019
First Posted
March 29, 2019
Study Start
May 15, 2019
Primary Completion
December 1, 2019
Study Completion
December 1, 2019
Last Updated
October 2, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share